SCHEMBL17870738

SCHEMBL17870738

CC1(NCCc2ccccc2[N+](=O)[O-])CCN(C(=O)O)CC1

nearest known ligand 0.44

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
SIGMAR1 Q99720 3/20 0.43
KDM4E B2RXH2 3/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
LMNA P02545 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
RAB9A P51151 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
POLB P06746 1/20 0.40
CYP2C19 P33261 1/20 0.40
KMT2A Q03164 2/20 0.40
ACHE P22303 1/20 0.40
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17870736 1.00 ALDH1A1 (0.43) ALDH1A1SIGMAR1KDM4ESMN1; SMN2LMNA
SCHEMBL19873972 0.83 SIGMAR1 (0.39) ALDH1A1SIGMAR1KDM4ESMN1; SMN2LMNA
SCHEMBL17870796 0.83 SIGMAR1 (0.52) ALDH1A1SIGMAR1SMN1; SMN2LMNARAB9A
SCHEMBL17870798 0.83 SIGMAR1 (0.52) ALDH1A1SIGMAR1SMN1; SMN2LMNARAB9A
SCHEMBL17870745 0.82 CYP2C19 (0.37) ALDH1A1SIGMAR1RAB9ACYP2C19KMT2A
SCHEMBL3958147 0.78 HTT (0.44) ALDH1A1LMNATDP1RAB9AL3MBTL1
SCHEMBL1813803 0.76 ALDH1A1 (0.55) ALDH1A1SIGMAR1KDM4ERAB9AL3MBTL1
SCHEMBL1813802 0.76 ALDH1A1 (0.55) ALDH1A1SIGMAR1KDM4ERAB9AL3MBTL1
SCHEMBL27644978 0.76 RAB9A (0.44) ALDH1A1SIGMAR1KDM4ESMN1; SMN2LMNA
SCHEMBL23236146 0.72 DPP4 (0.44) ALDH1A1SMN1; SMN2LMNATDP1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3708566-A1 NOVEL HETEROCYCLIC COMPOUNDS AND THE USE THEREOF IN MEDICINE AND IN COSMETICS Galderma Research & Development (FR) 2020-09-16 EP disclosed
EP-3237403-B1 NOVEL HETEROCYCLIC COMPOUNDS AND THE USE THEREOF IN MEDICINE AND IN COSMETICS GALDERMA RES & DEV (FR) 2020-05-06 EP disclosed
EP-3237403-A1 NOVEL HETEROCYCLIC COMPOUNDS AND THE USE THEREOF IN MEDICINE AND IN COSMETICS Galderma Research & Development (FR) 2017-11-01 EP disclosed
WO-2016102882-A1 NOVEL HETEROCYCLIC COMPOUNDS AND THE USE THEREOF IN MEDICINE AND IN COSMETICS GALDERMA RESEARCH & DEVELOPMENT (FR) 2016-06-30 WO disclosed